CRP and Sacroiliac arthritis: As depicted in Table 2, axSpA patients with degraded bone/low TBS group had higher CRP levels, disease activity scores (including PGA, BASDAI, BASFI, BASMI, and ASDAS), and prevalence of grade 4 sacroiliitis and current NSAIDs use than those in normal and high TBS groups.